- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
München, Ludwig-Maximilians-Universität, Dissertation, 2023
- Keyword
-
Maus
Gentherapie
Tiermodell
- Event
-
Veröffentlichung
- (where)
-
München
- (who)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (when)
-
2023
- Creator
- Contributor
-
Wolf, Eckhard
- DOI
-
10.5282/edoc.32474
- URN
-
urn:nbn:de:bvb:19-324744
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wilk, Ulrich Joachim
- Wolf, Eckhard
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Time of origin
- 2023
Other Objects (12)
Chemically modified mRNA Therapeutics for Bone Regeneration
RNA medicines in vivo: delivery of mRNA, siRNA, PMOs and Cas9 mRNA/sgRNA
How mRNA therapeutics are entering the monoclonal antibody field
Mapping global public perspectives on mRNA vaccines and therapeutics
GIGYF recruits mRNA decay factors to repress target mRNA expression
Nuclear mRNA maturation and mRNA export control: from trypanosomes to opisthokonts
Development of an Inhalable Dry Powder Platform for mRNA Therapeutics
Tumor-targeted delivery of Cas9 mRNA and sgRNA against KRAS-mutated lung cancer
Optimized RNA interference therapeutics combined with interleukin-2 mRNA for treating hepatitis B virus infection
HIV-1 mRNA knockdown with CRISPR/CAS9 enhances neurocognitive function
Assembling the RNA therapeutics toolbox
RNA-controlled nucleocytoplasmic shuttling of mRNA decay factors regulates mRNA synthesis and a novel mRNA decay pathway
Chemically modified mRNA Therapeutics for Bone Regeneration
RNA medicines in vivo: delivery of mRNA, siRNA, PMOs and Cas9 mRNA/sgRNA
How mRNA therapeutics are entering the monoclonal antibody field
Mapping global public perspectives on mRNA vaccines and therapeutics
GIGYF recruits mRNA decay factors to repress target mRNA expression
Nuclear mRNA maturation and mRNA export control: from trypanosomes to opisthokonts
Development of an Inhalable Dry Powder Platform for mRNA Therapeutics
Tumor-targeted delivery of Cas9 mRNA and sgRNA against KRAS-mutated lung cancer
Optimized RNA interference therapeutics combined with interleukin-2 mRNA for treating hepatitis B virus infection
HIV-1 mRNA knockdown with CRISPR/CAS9 enhances neurocognitive function
Assembling the RNA therapeutics toolbox
RNA-controlled nucleocytoplasmic shuttling of mRNA decay factors regulates mRNA synthesis and a novel mRNA decay pathway
Chemically modified mRNA Therapeutics for Bone Regeneration
RNA medicines in vivo: delivery of mRNA, siRNA, PMOs and Cas9 mRNA/sgRNA
How mRNA therapeutics are entering the monoclonal antibody field
Mapping global public perspectives on mRNA vaccines and therapeutics
GIGYF recruits mRNA decay factors to repress target mRNA expression
Nuclear mRNA maturation and mRNA export control: from trypanosomes to opisthokonts
Development of an Inhalable Dry Powder Platform for mRNA Therapeutics
Tumor-targeted delivery of Cas9 mRNA and sgRNA against KRAS-mutated lung cancer
Optimized RNA interference therapeutics combined with interleukin-2 mRNA for treating hepatitis B virus infection
HIV-1 mRNA knockdown with CRISPR/CAS9 enhances neurocognitive function
Assembling the RNA therapeutics toolbox